In fact, as many as 35% of people with IBD have some kind of oral manifestation of the condition, such as canker sores, the gum disease gingivitis, cavities, and angular cheilitis, which causes ...

Novartis will partner with PTC Therapeutics to develop PTC’s PTC518 Huntington's disease program and an unspecified number of related molecules, through an up-to-$2.9 billion exclusive global license ...